Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients.
Stephen Tsang, MD, PhD
Advertisement
Articles by Stephen Tsang, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Ocugen completes dosing early in phase 2/3 GARDian3 trial for Stargardt disease
2
FDA expands faricimab label to include treatment of macular edema secondary to retinal vein occlusion beyond 6 months
3
Tattoo-associated uveitis: An emerging eye health challenge
4
OLN324 shows comparable vision gains, potential durability advantage vs faricimab in phase 1b wAMD, DME study
5